| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Williams Donald Allen serves as a Director at PALI and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 9 buys and 0 sells. Those positions are worth an estimated $2.4M at current prices.
Historically, Williams Donald Allen's trades have earned a below-average insider score of 21/100 across 4 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -75.2%.
The biggest single holding is PALI (~$2.3M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 61,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | PALI Palisade Bio, Inc. | Director | Buy | 20,000 | $1.44 | $28,800.00 | +1.3% | - | - | |
| Jan 16, 2026 | PALI Palisade Bio, Inc. | Director | Buy | 5,000 | $1.67 | $8,356.00 | +87.3% | +40.4% | - | |
| Jan 9, 2026 | PALI Palisade Bio, Inc. | - | Buy | 5,000 | $1.88 | $9,400.00 | +686.8% | -0.5% | - | |
| May 28, 2024 | PALI Palisade Bio, Inc. | Director | Buy | 1,000 | $4.86 | $4,863.00 | New | -27.7% | -83.9% | |
| Jan 31, 2024 | PALI Palisade Bio, Inc. | Director | Buy | 10,000 | $0.61 | $6,050.00 | +50.0% | -32.9% | -84.1% | |
| Sep 27, 2023 | PALI Palisade Bio, Inc. | Director | Buy | 20,000 | $0.54 | $10,800.00 | New | +12.4% | -57.7% | |
| Mar 12, 2019 | ATEC Alphatec Holdings, Inc. | Director | Buy | 4,000 | $2.47 | $9,890.00 | +9.4% | - | - | |
| May 5, 2015 | ATEC Alphatec Holdings, Inc. | Director | Buy | 5,000 | $1.32 | $6,600.00 | +16.1% | - | - |